Successful treatment of supraventricular tachycardia with metoprolol, a cardioselective beta blocker.
Paroxysmal supraventricular tachycardia is a common problem in infancy and childhood. Past treatment has included digitalis and nonselective beta blockers (propranolol). We describe a new mode of therapy with a cardioselective beta blocker (metoprolol) that may be of use in patients resistant to standard therapy.
D001986:Bronchial Spasm / Q000139:chemically induced; D004077:Digoxin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D008790:Metoprolol / Q000627:therapeutic use*; D011412:Propanolamines / Q000627:therapeutic use*; D011433:Propranolol / Q000009:adverse effects; D012893:Sleep Wake Disorders / Q000139:chemically induced; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy*
D011412:Propanolamines; D004077:Digoxin; D011433:Propranolol; D008790:Metoprolol